RETINAL DEGENERATION

Clinical trials for RETINAL DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new RETINAL DEGENERATION trials appear

Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 5 Completed 1 Terminated 1

Experimental gene injection targets dry AMD

Disease control Terminated

This early-stage trial tested a gene therapy called GT005 for dry age-related macular degeneration (AMD), a leading cause of vision loss. The therapy delivers a working gene to the retina via a single injection. The study enrolled 56 people and focused on safety and dosing, but w…

Matched conditions: RETINAL DEGENERATION

Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

RETINAL DEGENERATION

Get alerted when new RETINAL DEGENERATION trials appear

Experimental gene injection targets dry AMD